CGI Pharmaceuticals, Inc

Investors

CGI Pharmaceuticals Inc. has raised over $62 million in private equity financing to date from premier venture firms. In April 2000, the Company raised $5 million in Series A financing with CHL Medical Partners and Connecticut Innovations, Inc. (CII) leading the round. A $22 million Series B round followed in March 2001. The Series B round was led by MPM Capital, together with new investors Flagship Ventures (AGTC Funds) and Vector Fund Management, as well existing investors CHL and CII.

In June 2004, the company completed the final closing of an oversubscribed Series C private equity financing raising a total of $34.9 million. The Series C round was led by Lilly BioVentures and was joined by new investors CDP Capital, Coastview Capital, Emerging Technology Partners, RiverVest Venture Partners and Toucan Capital Corporation, as well as previous investors Connecticut Innovations, Flagship Ventures, MPM Capital, and Vector Fund Management.

Major Investors